Opendata, web and dolomites

WEB-RADR 2 SIGNED

WEB-RADR 2

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "WEB-RADR 2" data sheet

The following table provides information about the project.

Coordinator
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY 

Organization address
address: 151 BUCKINGHAM PALACE ROAD
city: LONDON
postcode: SW1W 9SZ
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 2˙121˙879 €
 EC max contribution 1˙168˙750 € (55%)
 Programme 1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
 Code Call H2020-JTI-IMI2-2017-11-single-stage
 Funding Scheme IMI2-RIA
 Starting year 2018
 Duration (year-month-day) from 2018-09-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY UK (LONDON) coordinator 712˙500.00
2    INTERNATIONAL HEALTH TERMINOLOGY STANDARDS DEVELOPMENT ORGANISATION UK (LONDON) participant 238˙750.00
3    LAEGEMIDDELSTYRELSEN DK (KOBENHAVN S) participant 82˙500.00
4    STICHTING LAREB NL (S HERTOGENBOSCH) participant 62˙500.00
5    AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS ES (MADRID) participant 47˙500.00
6    Stiftelsen WHO Collaborating Centre for International Drug Monitoring SE (UPPSALA) participant 25˙000.00
7    ABBVIE INC US (NORTH CHICAGO IL) participant 0.00
8    CSL BEHRING GMBH DE (MARBURG) participant 0.00
9    NOVARTIS PHARMA AG CH (BASEL) participant 0.00
10    PFIZER LIMITED UK (SANDWICH) participant 0.00
11    THE INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE CH (GENEVE) participant 0.00

Map

 Project objective

This proposal seeks to build on the mobile application (app) functionality delivered through the original WEB-RADR project to expand access to the platform and the reach of the information contained within it. It will achieve this by making the functionality available through application programming interfaces (APIs), meaning that third party organisations will be able to embed WEB-RADR platform functionality into their own systems, applications and websites.

An important component to this will be a terminology/classification mapping activity involving the three core healthcare terminology owners; MedDRA MSSO, SNOMED International and WHO. The mapping will facilitate communication between regulatory and healthcare databases by establishing mapping protocols and delivering an initial mapping between a subset of key pharmacovigilance terms.

The project has established use cases and adopters for the proposed functionality through the networks established through the original WEB-RADR delivery, and has a diverse range of partners keen to utilise different aspects of the proposed solutions including regulatory authorities, health charities and system providers.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "WEB-RADR 2" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "WEB-RADR 2" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.)

AB-DiRecT (2019)

Antibiotic Distribution and Recovery in Tissue

Read More  

RespiriTB (2019)

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Read More  

EBOVAC3 (2018)

Bringing a prophylactic Ebola vaccine to licensure

Read More